(AVNT) Avient - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05368V1061
AVNT: Color Concentrates, Additives, Inks, Polymer Formulations
Avient Corporation is a leading formulator of material solutions, operating across a diverse range of geographies, including the United States, Canada, Mexico, Europe, South America, and Asia. The company's operations are segmented into two primary divisions: Color, Additives and Inks, and Specialty Engineered Materials. The Color, Additives and Inks segment is responsible for developing and manufacturing custom color and additive concentrates, dispersions, and specialty inks for a wide range of applications, including thermoplastics, thermosets, and liquid systems such as polyester, vinyl, and polyurethane. These products are utilized in various end-markets, including medical and pharmaceutical devices, food packaging, personal care and cosmetics, transportation, and building products, among others.
The Specialty Engineered Materials segment focuses on providing specialty polymer formulations, services, and solutions for designers, assemblers, and processors of thermoplastic materials. This segment caters to the needs of various industries, including healthcare, textiles, appliances, and industrial markets. Avient Corporation's products are sold through a combination of direct sales personnel, distributors, and commissioned sales agents, ensuring a robust and efficient distribution network. With a rich history dating back to 1885, the company has undergone significant transformations, including a name change from PolyOne Corporation to Avient Corporation in June 2020. Today, Avient Corporation is headquartered in Avon Lake, Ohio, and is listed on the New York Stock Exchange (NYSE) under the ticker symbol AVNT, with its common stock classified under the GICS Sub Industry of Specialty Chemicals.
As a global leader in the specialty chemicals industry, Avient Corporation is committed to delivering innovative material solutions that meet the evolving needs of its customers. With a strong presence in multiple regions and a diverse product portfolio, the company is well-positioned to capitalize on emerging trends and opportunities in the global marketplace. Avient Corporation's website, https://www.avient.com, provides detailed information on its products, services, and solutions, as well as its commitment to sustainability, innovation, and customer satisfaction. With an ISIN of US05368V1061, Avient Corporation's common stock is widely traded, offering investors a unique opportunity to participate in the growth and success of a leading specialty chemicals company.
Additional Sources for AVNT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AVNT Stock Overview
Market Cap in USD | 3,620m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 1999-09-13 |
AVNT Stock Ratings
Growth 5y | 34.9% |
Fundamental | 29.2% |
Dividend | 53.7% |
Rel. Strength Industry | 75.4 |
Analysts | 4.14/5 |
Fair Price Momentum | 39.15 USD |
Fair Price DCF | 46.30 USD |
AVNT Dividends
Dividend Yield 12m | 2.42% |
Yield on Cost 5y | 3.41% |
Annual Growth 5y | 4.90% |
Payout Consistency | 69.9% |
AVNT Growth Ratios
Growth Correlation 3m | -62% |
Growth Correlation 12m | 64% |
Growth Correlation 5y | 34.7% |
CAGR 5y | 7.10% |
CAGR/Mean DD 5y | 0.31 |
Sharpe Ratio 12m | 0.56 |
Alpha | -17.56 |
Beta | 1.43 |
Volatility | 34.88% |
Current Volume | 389.1k |
Average Volume 20d | 564.1k |
As of January 22, 2025, the stock is trading at USD 43.18 with a total of 389,142 shares traded.
Over the past week, the price has changed by +7.55%, over one month by +5.32%, over three months by -11.24% and over the past year by +18.32%.
Neither. Based on ValueRay Fundamental Analyses, Avient is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 29.23 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AVNT as of January 2025 is 39.15. This means that AVNT is currently overvalued and has a potential downside of -9.33%.
Avient has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy AVNT.
- Strong Buy: 4
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, AVNT Avient will be worth about 43 in January 2026. The stock is currently trading at 43.18. This means that the stock has a potential downside of -0.49%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 59 | 36.6% |
Analysts Target Price | 59 | 36.6% |
ValueRay Target Price | 43 | -0.5% |